SCHEMBL14021288

SCHEMBL14021288

C[C@H](O)CN1CCN(C(=O)c2ccc(Nc3nccc(-c4ccc(Cl)cc4)n3)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 1/20 0.51
▸ CDK2 P24941 1/20 0.51
▸ JAK2 O60674 6/20 0.49
▸ JAK3 P52333 4/20 0.49
▸ IKBKB O14920 3/20 0.49
▸ PIK3CA P42336 2/20 0.48
▸ PIK3CB P42338 2/20 0.48
▸ PIK3CG P48736 2/20 0.48
▸ JAK1 P23458 2/20 0.47
▸ CHUK O15111 2/20 0.47
▸ HDAC3 O15379 1/20 0.47
▸ NCOR1 O75376 1/20 0.47
▸ TYK2 P29597 1/20 0.47
▸ HDAC1 Q13547 1/20 0.47
▸ HDAC2 Q92769 1/20 0.47
▸ HDAC8 Q9BY41 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ MAPKAPK2 P49137 1/20 0.47
▸ AIMP2 Q13155 1/20 0.46
▸ MTOR P42345 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14021289 1.00 CDK1 (0.51) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL8312315 0.92 CDK1 (0.54) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL8311018 0.89 JAK2 (0.61) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL14021629 0.88 JAK2 (0.54) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL13590765 0.87 JAK2 (0.51) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL14021233 0.87 CDK1 (0.49) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL4392408 0.86 PIK3CA (0.51) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL3049760 0.86 SYK (0.51) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL8312148 0.86 CDK1 (0.62) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL1512786 0.86 PIK3CA (0.55) CDK1CDK2JAK2JAK3IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
Send feedback